Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-23-021633
Filing Date
2023-02-14
Accepted
2023-02-14 16:13:33
Documents
1
Group Members
KOH, BONGSHAH, NIMISHVENROCK HEALTHCARE CAPITAL PARTNERS EG, L.P.VENROCK HEALTHCARE CAPITAL PARTNERS III, L.P.VHCP CO-INVESTMENT HOLDINGS II, LLCVHCP CO-INVESTMENT HOLDINGS III, LLCVHCP MANAGEMENT EG, LLCVHCP MANAGEMENT II, LLCVHCP MANAGEMENT III, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm236635d2_sc13ga.htm SC 13G/A 264417
  Complete submission text file 0001104659-23-021633.txt   266326
Mailing Address 7 BRYANT PARK 23RD FLOOR NEW YORK NY 10018
Business Address 7 BRYANT PARK 23RD FLOOR NEW YORK NY 10018 650 475 3734
Venrock Healthcare Capital Partners II, L.P. (Filed by) CIK: 0001602264 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 103 CARNEGIE CENTER DRIVE, SUITE 309 PRINCETON NJ 08540
Business Address 103 CARNEGIE CENTER DRIVE, SUITE 309 PRINCETON NJ 08540 (609) 486-2308
LianBio (Subject) CIK: 0001831283 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-93022 | Film No.: 23629413
SIC: 2834 Pharmaceutical Preparations